MS Patients on Anti-CD20 Therapy May Benefit from COVID Booster
:max_bytes(150000):strip_icc()/brano-QSuou3VAtf4-unsplash-de657fc5880046b493909ea2e02262dc.jpeg "COVID-19 Booster Shots: Are They Variant-Specific?")
COVID-19 Booster Shots: Are They Variant-Specific?
Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis - eBioMedicine
Vaccines | Free Full-Text | Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab
Frontiers | Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study
MS and COVID-19 Vaccines - Advice & Support | MS Society
Queen Mary University of London
Breakthrough COVID-19 in Patients With Multiple Sclerosis: Snapshot From One Data Registry – Consult QD
Response to COVID-19 boosters in seronegative multiple sclerosis patients
Vaccines | Free Full-Text | Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis
Vaccines | Free Full-Text | Neurological Disorders following COVID-19 Vaccination
Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry - Multiple Sclerosis and Related Disorders
COVID-19, Vaccinations & Multiple Sclerosis - Practical Neurology
The ME Association: Covid Autumn Booster Vaccine Information (2023) - The ME Association
Certain immune-suppressing therapies reduce vaccine response in subset of multiple sclerosis patients | Ohio State Medical Center
T-cell response to Omicron after an mRNA COVID vaccine booster
Factsheet: COVID-19 Vaccine Guidance for People Living with Multiple Sclerosis (English, Spanish) | Vaccine Resource Hub
Studying the COVID-19 Vaccine in Autoimmune and Immunocompromised Patients
New Data Show COVID-19 Vaccine Does Not Raise Stroke Risk
COVID-19 booster jabs for people with MS this autumn | MS Society
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic | Journal of Neurology, Neurosurgery & Psychiatry
SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study - The Lancet Regional Health – Europe
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point | Neurology and Therapy
SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study - The Lancet Regional Health – Europe
Vaccines | Free Full-Text | Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
COVID-19 mRNA vaccines: Platforms and current developments: Molecular Therapy
